# Investigating the Acute Effects of Increasing Alanine Exposure in Healthy Participants

> **NCT07350512** · NA · NOT_YET_RECRUITING · sponsor: **Nicolai Jacob Wewer Albrechtsen** · enrollment: 15 (estimated)

## Conditions studied

- Glucose Metabolism
- Glucagon

## Interventions

- **OTHER:** alanine

## Key facts

- **NCT ID:** NCT07350512
- **Lead sponsor:** Nicolai Jacob Wewer Albrechtsen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-20
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-01-20
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07350512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07350512, "Investigating the Acute Effects of Increasing Alanine Exposure in Healthy Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07350512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
